by Nicolas Oberndorfer | Jun 17, 2020 | Dermapharm Corporate News, News
Corporate news to the archive Dermapharm Holding SE: Annual General Meeting approves dividend payout of EUR 0.80 per share Annual General Meeting successfully held virtually Management Board and Supervisory Board discharged by a large majority Important milestones...
by Nicolas Oberndorfer | May 19, 2020 | Dermapharm Corporate News, News, Uncategorized
Corporate news to the archive Dermapharm Holding SE: Growth in the first quarter of 2020 despite the corona pandemic Group revenues increased by 17.7% to EUR 192.5 million Adjusted Group EBITDA rose by 13.0% to EUR 49.4 million Corona pandemic leads to increased...
by Nicolas Oberndorfer | Apr 8, 2020 | Dermapharm Corporate News, News
Corporate news to the archive Dermapharm confirms profitable growth in 2019 and presents positive outlook for 2020 despite corona Significant revenue and earnings growth in 2019 resulted from continuous product development, further internationalization and successful...
by Nicolas Oberndorfer | Mar 31, 2020 | Dermapharm Corporate News, News
Corporate news to the archive Dermapharm successfully acquires Allergopharma Grünwald, March 31, 2020 – Dermapharm Holding SE (“Dermapharm”), a leading manufacturer of patent-free branded pharmaceuticals for selected therapeutic areas, successfully...
by Nicolas Oberndorfer | Mar 30, 2020 | Dermapharm Corporate News, News
Corporate news to the archive Dermapharm continues its profitable growth in 2019 » Group revenue of EUR 701 million in 2019, around 23% higher than in the previous year » Adjusted EBITDA increases by approx. 24% compared to last year to EUR 178...
by Nicolas Oberndorfer | Feb 5, 2020 | Dermapharm Corporate News, News
Corporate News to the archive Dermapharm opens new logistics center in Brehna Centralisation of logistics and expansion of the production space to approximately 12,000 m2 Short distances between production and logistics ensure the best possible availability of goods...
